Yard Force Showcases Cutting-Edge Innovations at Spoga Gafa 2024
27.6.2024 19:06:00 CEST | Business Wire | Press Release
Yard Force is proud to announce the successful presentation of its latest groundbreaking garden tools and robotic mowers at Spoga Gafa 2024, held in Cologne, Germany, from June 24-26, 2024. The event provided an excellent platform for Yard Force to demonstrate its commitment to innovation and excellence in garden care technology.
Revolutionizing Lawn Care with Yard Force Virtual Boundary Robotic Mowers:
- iVR10: This state-of-the-art model is equipped with Real-Time Kinematic (RTK) technology, Visual Simultaneous Localization and Mapping (VSLAM), and RGB cameras, ensuring pinpoint accuracy and exceptional performance. The 4-wheel drive system and multiple cutting patterns allow the iVR10 to tackle any terrain with ease, delivering a flawless lawn.
- i400: Designed for simplicity and efficiency, the i400 model features an RGB camera that enhances its navigation capabilities, making it an ideal choice for homeowners seeking reliable and consistent lawn maintenance.
- iV6: Combining the advanced navigation of VSLAM with the precision of RGB cameras, the iV6 offers superior maneuverability and cutting performance, adapting effortlessly to various lawn conditions.
Enhanced Performance with Yard Force Riding Mowers and ZTR Models:
Yard Force’s new riding mowers and ZTRs are engineered to provide unparalleled power and efficiency. Featuring ergonomic designs and robust engines, these models ensure smooth operation and exceptional cutting performance, making them perfect for large-scale lawn maintenance tasks.
Innovative 20V x 2 Lawn Mowers with One-Button Cutting Height Adjustment:
The latest range of Yard Force 20V x 2 lawn mowers introduces a revolutionary one-button cutting height adjustment feature. This innovation allows users to effortlessly switch between cutting heights, ensuring precise and tailored lawn care with minimal effort.
High-Pressure Washers for Superior Cleaning:
Yard Force's new high-pressure washers are designed to handle the most demanding cleaning tasks. These powerful tools offer high performance and durability, making them ideal for maintaining outdoor spaces in pristine condition.
A Successful Showcase at Spoga Gafa 2024:
At Spoga Gafa 2024, Yard Force’s booth attracted significant attention from industry professionals, retailers, and garden enthusiasts. The event highlighted Yard Force’s dedication to advancing garden care technology and its ability to meet the evolving needs of consumers.
About Yard Force:
Yard Force is a leading global brand in innovative garden tools and outdoor power equipment. Known for its commitment to quality, performance, and customer satisfaction, Yard Force continuously strives to deliver products that enhance the gardening experience. With a focus on cutting-edge technology and user-friendly designs, Yard Force is dedicated to helping consumers achieve the perfect garden.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240627381649/en/
Contacts
Media:
Yinlu Lin
carl@yardforce.eu
+86-25-58638031
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom